MARCH, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: ANALYTICAL AND IMMUNOLOGICAL TESTING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,399,258 | Biological markers for longevity and diseases and uses thereof | Albert Einstein College of Medicine of Yeshiva University | 19-Mar-13 | United States |
8,394,612 | Method for production of an L-amino acid | Ajinomoto Co., Inc. | 12-Mar-13 | Japan |
8,394,610 | Method for constructing an operon containing translationally coupled genes | Ajinomoto Co., Inc. | 12-Mar-13 | Japan |
8,404,438 | Probes for detection of SULT1A1 gene, reagent containing the same, and the uses thereof | Arkray, Inc. | 26-Mar-13 | Japan |
8,399,217 | High density growth of T7 expression strains with auto-induction option | Brookhaven Science Associates, LLC | 19-Mar-13 | United States |
8,389,252 | Yeast strain for production of four carbon alcohols | Butamax(TM) Advanced Biofuels LLC | 5-Mar-13 | United States |
8,389,238 | Long-term in vivo transgene expression | Copernicus Therapeutics, Inc. | 5-Mar-13 | United States |
8,399,218 | Engineered zinc finger proteins targeting 5-enolpyruvyl shikimate-3-phosphate synthase genes | Dow AgroSciences, LLC | 19-Mar-13 | United States |
8,389,258 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,257 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,256 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,255 | Perhydrolase providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,254 | Perhydrolase providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,260 | Perhydrolase variant providing improved specific activity | E. I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,389,259 | Perhydrolase variant providing improved specific activity | E.I. du Pont de Nemours and Company | 5-Mar-13 | United States |
8,394,616 | Perhydrolase variant providing improved specific activity | E.I. du Pont de Nemours and Company | 12-Mar-13 | United States |
8,399,234 | Perhydrolase variant providing improved specific activity | E.I. du Pont de Nemours and Company | 19-Mar-13 | United States |
8,394,617 | Perhydrolase variant providing improved specific activity | E.I. du Pont de Nemours and Company | 12-Mar-13 | United States |
8,399,200 | Isolation of allergen-specific immunoglobulin genes from human B-cells from atopy sufferers | Fraunhofer-Gesellschaft zur Forderung der angewandten Forschung e.V | 19-Mar-13 | Germany |
8,389,264 | Recombinant microorganism that expresses a secY gene with deletion of sporulation-associated genes and method of producing thereof | Kao Corporation | 5-Mar-13 | Japan |
8,399,256 | Method for introducing gene into cell, and composition for use in the method | Mitsubishi Gas Chemical Company, Inc. | 19-Mar-13 | Japan |
8,389,265 | Gene associated with foam formation of acetic acid bacterium, acetic acid bacterium bred by modifying the gene and method for producing vinegar using the acetic acid bacterium | Mizkan Group Corporation | 5-Mar-13 | Japan |
8,404,477 | Bacillus licheniformis and method for detoxification of zearalenone | National Taiwan University | 26-Mar-13 | Taiwan |
8,389,239 | Enhanced expression and stability regions | Regeneron Pharmaceuticals, Inc. | 5-Mar-13 | United States |
8,389,213 | Method for concentration of gene | Suntory Holdings Limited | 5-Mar-13 | Japan |
8,394,598 | Tyrosine kinome | The Johns Hopkins University | 12-Mar-13 | United States |
8,389,276 | Immortalized mouse fibroblast cell lines deficient in Bax and/or Bak | The Trustees of the University of Pennsylvania | 5-Mar-13 | United States |
8,394,613 | Polyhydroxyalkanoic acid copolymer and process for preparing same | Tokyo Institute of Technology | 12-Mar-13 | Japan |
8,394,628 | RNA sequence-specific mediators of RNA interference | University of Massachusetts | 12-Mar-13 | United States |
8,404,472 | System for producing aromatic molecules by bioconversion | V. Mane Fils | 26-Mar-13 | France |
COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,394,742 | Methods, compounds and compositions with genotype selective anticancer activity | The Translation Genomics Research Institute | 12-Mar-13 | United States |
DATA PROCESSING | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,392,127 | Methods and gene expression signature for assessing growth factor signaling pathway regulation status | Merck Sharp & Dohme Corp | 5-Mar-13 | United States |
8,396,673 | Gene assaying method, gene assaying program, and gene assaying device | Sony Corporation | 12-Mar-13 | Japan |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,394,388 | Mycobacterial mutants affecting host apoptosis | Albert Einstein College of Medicine of Yeshiva University | 12-Mar-13 | United States |
8,388,971 | Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses | Amgen Fremont Inc. | 5-Mar-13 | United States |
8,399,424 | Method for controlling the amount of gene product, and agent for controlling the amount of gene product | Amino Up Chemical Co., Ltd | 19-Mar-13 | Japan |
8,389,487 | siRNA-mediated gene silencing of synuclein | Ann & Robert Lurie Children's Hospital of Chicago | 5-Mar-13 | United States |
8,394,761 | Methods for treating congestive heart failure | Beth Israel Deaconess Medical Center | 12-Mar-13 | United States |
8,399,426 | Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA | Bioinfra Inc. | 19-Mar-13 | Korea |
8,398,968 | Adenoviral expression vectors | Canji Inc. | 19-Mar-13 | United States |
8,394,777 | Treating immunodeficiencies by intrathymic injection of nucleotide sequences | Centre National de la Recherche Scientifique | 12-Mar-13 | France |
8,404,657 | Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (Tlx) | DKFZ Deutsches Krebsforschungszentrum, Stiftung des Oeffentlichen Rechts | 26-Mar-13 | Germany |
8,388,980 | Yeast-based therapeutic for chronic hepatitis C infection | GlobeImmune, Inc. | 5-Mar-13 | United States |
8,389,535 | L-methylfolate treatment for psychiatric or neurologic disorders | Quillin; Robert L. | 5-Mar-13 | United States |
8,404,652 | DNA-binding protein YB-1-containing collagen accumulation inhibitors | Sumitomo Chemical Company, Limited | 26-Mar-13 | United States |
8,389,491 | Bispecific antisense oligonucleotides that inhibit IGFBP-2 and IGFBP-5 and methods of using same | The University of British Columbia | 5-Mar-13 | Canada |
8,389,485 | Encapsulated nanoparticles for nucleic acid delivery | University of Massachusetts | 5-Mar-13 | United States |
8,389,492 | Lyophilized DNA formulations for enhanced expression of plasmid DNA | ViroMed Co., Ltd. | 5-Mar-13 | Korea |
FOOD OR EDIBLE MATERIAL | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,389,033 | Modified industrial yeast strains | The Australian Wine Research Institute Ltd | 5-Mar-13 | Australia |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,389,794 | Transgenic pig as a model of Alzheimer's disease | Aarhus Universitet | 5-Mar-13 | Denmark |
8,395,023 | Recombinant DNA constructs and methods for controlling gene expression | Monsanto Technology LLC | 12-Mar-13 | United States |
8,399,735 | Hydroxysteroid dehydrogenase gene for alteration of plant phenotype | National Research Council of Canada | 19-Mar-13 | Canada |
8,389,795 | Vectors and methods for the mutagenesis of mammalian genes | Omeros Corporation | 5-Mar-13 | United States |
8,404,929 | Compositions and methods for modulating expression of gene products | Pioneer Hi-Bred International, Inc. | 26-Mar-13 | United States |
8,395,021 | Highly active soybean promoter from the SUBI-3 polyubiquitin gene and uses thereof | The Ohio State University Research Foundation | 12-Mar-13 | United States |
8,399,737 | Functional R-gene from Solanum bulbocastanum | Wageningen Universiteit | 19-Mar-13 | Netherlands |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,394,932 | Survival motor neurons (SMN) gene: a gene for spinal muscular atrophy | Institut National de la Sante et de la Recherche Medicale | 12-Mar-13 | France |
8,389,681 | Methods for production of proteins | Life Technologies Corporation | 5-Mar-13 | United States |
8,404,807 | Mammalian tumor susceptibility genes and their uses | The Board of Trustees of the Leland Stanford Junior University | 26-Mar-13 | United States |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,404,862 | Ligand-conjugated monomers | Alnylam Pharmaceuticals, Inc. | 26-Mar-13 | United States |
8,404,822 | Probe, probe set, probe-immobilized carrier, and genetic testing method | Canon Kabushiki Kaisha | 26-Mar-13 | Japan |
8,399,654 | siRNA targeting catenin, Beat-1 (CTNNB1) | Dharmacon, Inc. | 19-Mar-13 | United States |
8,394,947 | Positionally modified siRNA constructs | Isis Pharmaceuticals, Inc. | 12-Mar-13 | United States |
8,404,823 | Cytokine production regulator gene and use thereof | Kabushiki Kaisha Yakult Honsha | 26-Mar-13 | Japan |
8,404,824 | Splice variants of human IL-23 receptor (IL-23R) mRNA and use of a .DELTA.9 isoform in predicting inflammatory bowel diseases | Medical Diagnostic Laboratories, LLC | 26-Mar-13 | United States |
8,394,936 | Methods and compositions for detecting serotypes of Chlamydia trachomatis capable of causing lymphogranuloma venereum | Medical Diagnostic Laboratories, LLC | 12-Mar-13 | United States |
8,404,829 | Predictive and therapeutic markers in ovarian cancer | The Regents of the University of California | 26-Mar-13 | United States |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.